Zhu Y - Search Results

1

Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.

Liu Y, Xiao Q, He J, Hu H, Du J, Zhu Y, Chen J, Liu Z, Wang J, Sun L, Xu D, Li J, Liao X, Wang J, Cai Y, Cai C, Jin Z, Wang L, Yuan Y, Ding K. Liu Y, et al. Among authors: zhu y. BMC Med. 2022 May 6;20(1):155. doi: 10.1186/s12916-022-02357-6. BMC Med. 2022. PMID: 35513832 Free PMC article. Clinical Trial.

2

Simultaneous radical cystectomy and colorectal cancer resection for synchronous muscle invasive bladder cancer and cT3 colorectal cancer: Our initial experience in five patients.

Liu Z, Chen G, Zhu Y, Li D. Liu Z, et al. Among authors: zhu y. J Res Med Sci. 2014 Oct;19(10):1012-5. J Res Med Sci. 2014. PMID: 25538788 Free PMC article.

3

Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer.

Jin T, Zhu Y, Luo JL, Zhou N, Li DC, Ju HX, Fan YT, Liu Y, Zhu YP, Feng HY, Liu LY. Jin T, et al. Among authors: zhu y, zhu yp. Int J Colorectal Dis. 2015 Mar;30(3):337-45. doi: 10.1007/s00384-014-2097-2. Epub 2015 Jan 8. Int J Colorectal Dis. 2015. PMID: 25564344 Clinical Trial.

4

Interleukin-11-induced capillary leak syndrome companied with abdominal chylous leakage in primary sigmoid carcinoma patients with thrombocytopenia.

Liu Z, Li de C, Zhu YP. Liu Z, et al. J Cancer Res Ther. 2015 Oct-Dec;11(4):1024. doi: 10.4103/0973-1482.148656. J Cancer Res Ther. 2015. PMID: 26881585 Free article.

5

The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.

Lu M, Liu Z, Li B, Wang G, Li D, Zhu Y. Lu M, et al. Among authors: zhu y. J Cancer Res Clin Oncol. 2017 Jan;143(1):71-81. doi: 10.1007/s00432-016-2252-y. Epub 2016 Sep 14. J Cancer Res Clin Oncol. 2017. PMID: 27629879

6

Smad3 mutant mice develop colon cancer with overexpression of COX-2.

Zhu YP, Liu Z, Fu ZX, Li DC. Zhu YP, et al. Oncol Lett. 2017 Mar;13(3):1535-1538. doi: 10.3892/ol.2017.5639. Epub 2017 Jan 25. Oncol Lett. 2017. PMID: 28454287 Free PMC article.

7

Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.

Zhu Y, Li B, Liu Z, Jiang L, Wang G, Lv M, Li D. Zhu Y, et al. Oncotarget. 2017 Dec 4;8(67):111715-111727. doi: 10.18632/oncotarget.22903. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340086 Free PMC article.

8

Integrative Analysis of the IQ Motif-Containing GTPase-Activating Protein Family Indicates That the IQGAP3-PIK3C2B Axis Promotes Invasion in Colon Cancer.

Liu Z, Li X, Ma J, Li D, Ju H, Liu Y, Chen Y, He X, Zhu Y. Liu Z, et al. Among authors: zhu y. Onco Targets Ther. 2020 Aug 20;13:8299-8311. doi: 10.2147/OTT.S257729. eCollection 2020. Onco Targets Ther. 2020. PMID: 32903879 Free PMC article.

9

Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.

Cai Y, Liu Z, Jiang L, Ma D, Zhou Z, Ju H, Zhu Y. Cai Y, et al. Among authors: zhu y. Front Endocrinol (Lausanne). 2022 Jul 21;13:871830. doi: 10.3389/fendo.2022.871830. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937823 Free PMC article.

10

The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1.

Zhu Y, Wang X, Zheng L, Li D, Liu Z, Teng L. Zhu Y, et al. J Oncol. 2022 Oct 10;2022:8130132. doi: 10.1155/2022/8130132. eCollection 2022. J Oncol. 2022. PMID: 36262350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,313 results

Search Page

Filters